These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21636036)

  • 1. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy.
    Minami Y; Kajimoto K; Terajima Y; Yashiro B; Okayama D; Haruki S; Nakajima T; Kawashiro N; Kawana M; Hagiwara N
    J Am Coll Cardiol; 2011 Jun; 57(23):2346-55. PubMed ID: 21636036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
    Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction.
    Efthimiadis GK; Pagourelias ED; Parcharidou D; Gossios T; Kamperidis V; Theofilogiannakos EK; Pappa Z; Meditskou S; Hadjimiltiades S; Pliakos C; Karvounis H; Styliadis IH
    Circ J; 2013; 77(9):2366-74. PubMed ID: 23728066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic overlap in hypertrophic cardiomyopathy: apical hypertrophy, midventricular obstruction, and apical aneurysm.
    Minami Y; Haruki S; Hagiwara N
    J Cardiol; 2014 Dec; 64(6):463-9. PubMed ID: 24768408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous apex to left ventricle blood flow pattern in hypertrophic cardiomyopathy with apical aneurysm and midventricular obstruction.
    Hsieh BP; Tauras J; Taub C
    Echocardiography; 2012 Jul; 29(6):E131-3. PubMed ID: 22329429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm formation in a single family: case report.
    Efthimiadis GK; Pliakos C; Pagourelias ED; Parcharidou DG; Spanos G; Paraskevaidis S; Styliadis IH; Parcharidis G
    Cardiovasc Ultrasound; 2009 Jun; 7():26. PubMed ID: 19527529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
    N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation.
    Minami Y; Haruki S; Yashiro B; Suzuki T; Ashihara K; Hagiwara N
    J Cardiol; 2016 Dec; 68(6):478-484. PubMed ID: 26908359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
    Maron BJ; Maron MS; Wigle ED; Braunwald E
    J Am Coll Cardiol; 2009 Jul; 54(3):191-200. PubMed ID: 19589431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraventricular flow dynamics in hypertrophic cardiomyopathy with midventricular obstruction investigated by Doppler echocardiography].
    Nakamura T; Kitamura H; Furukawa K; Matsubara K; Katahira T; Okamuro S; Tsuji Y; Takahashi T; Kunishige H; Katsume H
    J Cardiol; 1989 Jun; 19(2):455-71. PubMed ID: 2636627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm.
    Sanghvi NK; Tracy CM
    Pacing Clin Electrophysiol; 2007 Jun; 30(6):799-803. PubMed ID: 17547615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
    Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
    Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.
    Autore C; Bernabò P; Barillà CS; Bruzzi P; Spirito P
    J Am Coll Cardiol; 2005 Apr; 45(7):1076-80. PubMed ID: 15808767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy.
    Cui L; Tse G; Zhao Z; Bazoukis G; Letsas KP; Korantzopoulos P; Roever L; Li G; Liu T
    Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12638. PubMed ID: 30737990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Nie C; Zhu C; Xiao M; Yang Q; Meng Y; Wu R; Wang S
    Clin Cardiol; 2021 Apr; 44(4):555-562. PubMed ID: 33626191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obstruction on longitudinal left ventricular shortening in hypertrophic cardiomyopathy.
    Barac I; Upadya S; Pilchik R; Winson G; Passick M; Chaudhry FA; Sherrid MV
    J Am Coll Cardiol; 2007 Mar; 49(11):1203-11. PubMed ID: 17367665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.